CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,939,756
- in 9 filings, $1.9M under 10b5-1 plans
Net −$1,939,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-22 | Walsh Patrick D Director | Grant or award | +4,336 | 79,048 | ||
| 2025-05-22 | Pera Antonio R Director | Grant or award | +4,336 | 35,373 | ||
| 2025-05-22 | TANNENBAUM RENEE P Director | Grant or award | +4,336 | 26,957 | ||
| 2025-05-22 | HAUGHEY THOMAS Director | Grant or award | +4,336 | 55,862 | ||
| 2025-05-15 | Gutwerg Ori SVP, GENERICS | Sale | −881 | $60.07 | $53K | 89,897 |
| 2025-05-14 | Mutz Christopher HEAD OF RARE DISEASE | Sale | −4,000 | $60.45 | $242K | 107,317 |
| 2025-05-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −400 | $62.20 | $25K | 79,745 |
| 2025-05-09 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Sale 10b5-1 | −700 | $76.83 | $54K | 631,920 |
| 2025-04-14 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −400 | $68.96 | $28K | 80,145 |
| 2025-03-23 | Lalwani Nikhil PRESIDENT & CEO | Shares withheld for taxes | −17,455 | $64.26 | $1.1M | 468,179 |
| 2025-03-23 | CAREY STEPHEN P. SVP & CFO | Shares withheld for taxes | −6,210 | $64.26 | $399K | 180,863 |
| 2025-03-19 | Davis Krista SVP, CHIEF HR OFFICER | Sale 10b5-1 | −1,866 | $65.00 | $121K | 64,659 |
| 2025-03-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −400 | $63.33 | $25K | 80,545 |
| 2025-03-07 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −2,874 | $60.62 | $174K | 111,317 |
| 2025-03-07 | Gutwerg Ori SVP, GENERICS | Shares withheld for taxes | −3,314 | $60.62 | $201K | 90,778 |
| 2025-03-07 | Lalwani Nikhil PRESIDENT & CEO | Shares withheld for taxes | −17,060 | $60.62 | $1.0M | 485,634 |
| 2025-03-07 | CAREY STEPHEN P. SVP & CFO | Shares withheld for taxes | −5,150 | $60.62 | $312K | 187,073 |
| 2025-03-07 | Davis Krista SVP, CHIEF HR OFFICER | Sale 10b5-1 | −1,000 | $60.86 | $61K | 66,525 |
| 2025-03-05 | Gutwerg Ori SVP, GENERICS | Option exercise | +300 | $31.49 | $9K | 99,476 |
| 2025-03-05 | Gutwerg Ori SVP, GENERICS | Sale | −300 | $60.03 | $18K | 99,176 |
Page 8 of 23 · 442 trades